1. Home
  2. SCCO vs NVO Comparison

SCCO vs NVO Comparison

Compare SCCO & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern Copper Corporation

SCCO

Southern Copper Corporation

HOLD

Current Price

$179.91

Market Cap

155.9B

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$41.12

Market Cap

166.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCCO
NVO
Founded
1952
1923
Country
United States
Denmark
Employees
N/A
69500
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.9B
166.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SCCO
NVO
Price
$179.91
$41.12
Analyst Decision
Sell
Hold
Analyst Count
11
11
Target Price
$139.37
$51.00
AVG Volume (30 Days)
1.3M
13.6M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
2.20%
3.12%
EPS Growth
20.74
N/A
EPS
5.24
N/A
Revenue
$6,654,500,000.00
N/A
Revenue This Year
$18.08
N/A
Revenue Next Year
N/A
$3.70
P/E Ratio
$34.39
$13.60
Revenue Growth
23.69
N/A
52 Week Low
$86.33
$35.12
52 Week High
$223.89
$81.44

Technical Indicators

Market Signals
Indicator
SCCO
NVO
Relative Strength Index (RSI) 47.13 60.14
Support Level $124.89 $35.49
Resistance Level $198.93 $41.41
Average True Range (ATR) 6.75 0.99
MACD -0.19 0.40
Stochastic Oscillator 32.35 95.77

Price Performance

Historical Comparison
SCCO
NVO

About SCCO Southern Copper Corporation

Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: